Answers are grounded in this paper and cite their sources.
( Eur J Anaesthesiol . 2026;43(1):53–65. doi: 10.1097/EJA.0000000000002293) Postpartum hemorrhage (PPH) affects large proportions of women globally every year. Coagulation disorders do not often contribute to PPH initially; however, as blood loss increases, they become more prevalent. Acute obstetric coagulopathy has an incidence of 1 per 1000 deliveries and is a distinct type that affects PPH. Timely testing and intervention for this condition is imperative for proper treatment. This article is a narrative review of evidence surrounding viscoelastic testing (VHA) for the treatment of PPH, as well as evaluating the use of fibrinogen and tranexamic acid (TXA) for prophylactic and therapeutic use.
No takes yet. Share an insight, caveat, or question.
Vandersmissen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: